Yahoo India Web Search

Search results

  1. Concord Biotech IPO bidding started from August 4, 2023 and ended on August 8, 2023. The allotment for Concord Biotech IPO was finalized on Friday, August 11, 2023. The shares got listed on BSE, NSE on August 18, 2023. Concord Biotech IPO price band is set at705 to741 per share.

  2. Aug 7, 2023 · Concord Biotech IPO is a public issue of 20,925,652 equity shares. The issue offers 7,320,479 shares to retail investors, 4,183,130 shares to qualified institutional buyers, and 3,137,348 shares to non-institutional investors.

  3. Aug 18, 2023 · Concord Biotech IPO Details: Concord Biotech IPO date is fixed, the IPO is to hit the market on August 4 and will close on August 8, 2023. Concord Biotech IPO to raise around ₹1551 crores via IPO that comprises offer for sale up to 20,925,652 equity shares ₹10 each.

  4. Aug 1, 2023 · Concord Biotech IPO: Check issue details, latest GMP, price band, other key key things to know. The Rekha Jhunjhunwala-backed Concord Biotech IPO consists of a pure offer-for-sale (OFS)...

  5. The Concord Biotech IPO details have been declared. The Concord Biotech IPO lot size is set at 2 20 shares and an investor can apply for a minimum of 1 lot. Meanwhile, the Concord Biotech IPO issue size is approx1,551 crore.

  6. Aug 4, 2023 · August 04, 2023 / 09:12 AM IST. Concord Biotech opens for subscription on August 4 and will close on August 8. Big bull Rakesh Jhunjhunwala's RARE Enterprises-backed Concord Biotech will be...

  7. Jul 31, 2023 · Concord Biotech IPO price band has been fixed in the range between ₹ 705 to741 per equity share of face value of ₹ 1 each. Concord Biotech IPO lot size is 20 equity shares and in...

  8. Aug 1, 2023 · The initial public offering (IPO) of Concord Biotech will open for subscription on August 4. The issue closes on August 8. The company's shares are expected to get listed on both the exchanges.

  9. Aug 17, 2023 · Concord Biotech Limited IPO is all set to open from 4th August to 8th August 2023. Concord Biotech is an R&D-led biopharma company based out of India. The IPO includes an Offer-for-Sale (OFS) of 20,925,652 equity shares ₹1551 crore.

  10. Aug 4, 2023 · Concord Biotech IPO - Read Concord Biotech IPO Review and Analysis on The Economic Times. Find out Concord Biotech IPO Issue Price, Subscription Dates and Status, Concord Biotech IPO Listing Date and more.

  1. Searches related to concord biotech ipo

    tvs supply chain ipo
    sbfc finance ipo
    mankind pharma ipo
  1. People also search for